Building Advanced Cell Models for Toxicity Testing
Webinar

Building Advanced Cell Models for Toxicity Testing

In this webinar, Kevin Grady and Manisha Nautiyal will outline how to make predictive 2D and 3D models for pharmacological toxicity testing.  

Share

This webinar will be hosted live and available on-demand

Wednesday, May 15, 2024
11:00 AM- 12:00 PM ET

Life sciences researchers need a host of tools to develop and test critical disease-treating drugs and therapies, from basic research to final product release. Primary cells, media, and reagents are all important for supporting preclinical and clinical pharmaceutical workflows for drug discovery and absorption, distribution, metabolism, excretion, and toxicity (ADMET) testing. In particular, scientists can use primary cells to build advanced 2D and 3D predictive models for liver, skin, vascular, and respiratory toxicities, striving to better understand the pharmacokinetics and metabolism of new compounds.

In this webinar brought to you by Lonza, Kevin Grady and Manisha Nautiyal will review how primary human cells and optimized media systems can be the building blocks for developing the next generation of predictive in vitro ADMET solutions.  

Topics to be covered 

  • An introduction to primary cell lines and media systems for optimized toxicity testing
  • Evaluating toxicity in different parts of the body
  • Developing advanced, biologically-relevant models using a sophisticated portfolio of products and custom services
Kevin

Kevin Grady
Senior Market Development Manager
Lonza

Manisha Nautiyal

Manisha Nautiyal
Principal Scientist, R&D
Lonza

Sponsored by

  • Lonza

Top Image Credit:

3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide